Mori et al. [58] have found that deletion of pyruvate dehydrogenase kinase 4 (PDK4) prevented angiotensin II-induced cardiac hypertrophy and improved cardiac glucose oxidation and energy usage. Here, PDK4 is linked to cardiac hypertrophy.